However, expression of MALAT1 was not significantly associated with gender of patients (OR = 1.748; 95% CI: 0.440–6.951; p = 0.428) and tumor stage T (OR = 0.501; 95% CI: 0.225–1.120; p = 0.092). Here, MALAT1 is linked to neoplasm.